Leiomyosarcoma
Showing 1 - 25 of 52
Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)
Recruiting
- Leiomyosarcoma
-
Los Angeles, CaliforniaSarcoma Oncology Center
Oct 16, 2023
Metastatic Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Plasma Collection
-
Rochester, Minnesota
- +2 more
Jan 5, 2023
Localized Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Blood and Tissue collection
-
Ann Arbor, Michigan
- +3 more
Jan 5, 2023
Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)
Active, not recruiting
- Leiomyosarcoma
- +3 more
-
Taipei, Taiwan
- +1 more
Dec 27, 2022
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)
Recruiting
- Retroperitoneal Sarcoma
- +2 more
- Surgery
- Preoperative chemotherapy
-
Woolloongabba, Queensland, Australia
- +36 more
Dec 27, 2022
Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)
Recruiting
- Leiomyosarcoma
- Liposarcoma
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022
Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+
Recruiting
- Epstein-Barr Virus (EBV)-Associated Diseases
- +13 more
- Tabelecleucel
-
Los Angeles, California
- +39 more
Nov 9, 2022
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
People With Leiomyosarcoma
Not yet recruiting
- Leiomyosarcoma
- (no location specified)
Sep 16, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Leiomyosarcoma Trial in Toulouse (Blood samples will be collected at different times.)
Not yet recruiting
- Leiomyosarcoma
- Blood samples will be collected at different times.
-
Toulouse, FranceInstitut Universitaire du Cancer Toulouse - Oncopole
Aug 2, 2022
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)
Recruiting
- Liposarcoma, Myxoid
- +4 more
- Trabectedin
- Radiotherapy
-
Bordeaux, France
- +15 more
Jun 6, 2022
Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)
Recruiting
- Leiomyosarcoma
- Dinutuximab Beta, Zoledronic acid, Interleukin-2
-
Bad Saarow, Germany
- +1 more
Jun 2, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)
Recruiting
- Soft Tissue Sarcoma
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)
Active, not recruiting
- Uterine Cancer
- +6 more
-
Basking Ridge, New Jersey
- +7 more
Apr 4, 2022
Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)
Recruiting
- Leiomyosarcoma
- Temozolomide for injection combined with epirubicin
-
Beijing, Beijing, ChinaCancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021